Mental Health
News Category
NanoViricides Raises $3.8 Million in Registered Direct Offering to Advance Antiviral Drug Development
NanoViricides announced a $3.8 million registered direct offering to fund the development of its broad-spectrum antiviral drug candidate NV-387 and ot...
VERAXA Biotech Gains Regulatory Support for BiTAC®-TCE Development from Germany's Paul-Ehrlich-Institute
VERAXA Biotech received positive scientific advice from Germany's Paul-Ehrlich-Institute, reducing uncertainty for its lead BiTAC®-TCE program as it a...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations Ltd. is advancing its lead asset ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the...
Recent Disease Outbreaks Expose Public Health System Gaps, Fueling Demand for Point-of-Care Diagnostics
Recent outbreaks of measles, mpox, and HIV have highlighted critical weaknesses in U.S. public health systems, driving innovation in diagnostic tools ...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods
Lantern Pharma (NASDAQ: LTRN) announced a U.S. patent allowance for methods selecting patients for LP-184 therapy using a three-gene biomarker signatu...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform for Solid Tumor Therapies
VERAXA Biotech has appointed Christoph Erkel, Ph.D., as Chief Scientific Officer to lead the development of its proprietary BiTAC platform technologie...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives has completed commercial manufacturing and logistics supply chain readiness to launch its MyndSystem and Xcellara wellness platforms next...
Quantum BioPharma Targets Two Major Neurological Conditions with Novel Pipeline
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in brain diso...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Everolimus Formulation Sapu003
The publication of preclinical data for Sapu003, an intravenous formulation of everolimus, supports its ongoing Phase 1 clinical trial and validates O...
NanoViricides Seeks DRC Approval for Phase II Ebola Trial of Oral Antiviral NV-387
NanoViricides has applied to begin a Phase II trial of its oral antiviral NV-387 against the Bundibugyo ebolavirus outbreak in the DRC, potentially of...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate cancer, ai...
VERAXA Biotech Receives Positive Regulatory Feedback from German PEI for BiTAC-TCE Program
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC-TCE candida...
Greenwich LifeSciences Provides Update on Phase 3 FLAMINGO-01 Trial, Including Expanded Enrollment and Positive DSMB Recommendation
Greenwich LifeSciences announced that its Phase 3 trial for GLSI-100, an immunotherapy to prevent breast cancer recurrence, received a positive recomm...
Quantum BioPharma Develops Two-Pronged Attack on Brain Disorders Affecting Millions
Quantum BioPharma Ltd. is advancing a pipeline targeting multiple sclerosis and alcohol intoxication with novel therapies, addressing significant unme...
Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer
A World Health Organization-commissioned review of 13 studies found no evidence that mobile phone use causes brain cancer, shifting focus to treatment...
Quantum BioPharma Hits Key Study Milestone with Promising Early MS Imaging Data
Quantum BioPharma announced that its imaging study for multiple sclerosis has reached halfway enrollment with encouraging preliminary results, potenti...
GeoVax Highlights Alignment of GEO-MVA with HHS/ASPR's Five-Year Preparedness Strategy
GeoVax Labs announces that its GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year medical countermeasure strategy emphasizing domestic manu...
Gut microbiome emerges as key player in biliary atresia — could targeting bacteria improve outcomes for infants?
A comprehensive review reveals that imbalanced gut microbiome in infants with biliary atresia is linked to poorer outcomes, suggesting microbiome-modu...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, clarifying the development path and suppor...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech AG received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on development strate...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials received a Japan patent allowance for its proprietary GelrinC manufacturing process, strengthening its IP portfolio and position...
Gut Microbial Metabolites Linked to Improved Cancer Immunotherapy Response
A study reveals that metabolites from certain gut bacteria can enhance the effectiveness of cancer immunotherapy, offering potential for new treatment...
Topiramate Market to Reach USD 39.6 Million by 2036, Driven by Generic Drug Production and Regulatory Compliance
The global Topiramate market is projected to grow steadily to USD 39.6 million by 2036, driven by increased generic antiepileptic drug production and ...
New Garlic Varieties Show Antiviral Potential, Research Suggests
Peer-reviewed studies indicate that specific garlic cultivars possess antiviral properties against COVID and influenza, leading to new garlic-based he...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its cellular wellness platform, backed by a clinical trial showing a 268.8% increase in stem cells, as it prepares to launch the...
NeuroOne Expands Drug Delivery Platform Through Collaboration with Mayo Clinic on Pediatric Brain Cancer Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic to evaluate a novel treatment for pediatric diffuse midline glioma using its ...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Aid Biotech Development
Oncotelic Therapeutics has introduced an AI-driven manufacturing services platform combining its PDAOAI architecture with robotics from TechForce Robo...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma's LUCID-MS, a neuroprotective therapy for multiple sclerosis targeting myelin repair, shows favorable safety in Phase 1 and moves to...
VERAXA Biotech's AI Collaboration Could Unlock New Potential in Cancer Drug Development
VERAXA Biotech's partnership with Ardigen leverages AI to enhance its BiTAC(R) oncology platform, potentially improving target discovery and reducing ...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
Tonix Pharmaceuticals announced new preclinical research showing significant differences in virulence between mpox virus clades, supporting the develo...
Regentis Biomaterials Receives European Approval for Next-Generation GelrinC Manufacturing Process
Regentis Biomaterials has obtained European Notified Body approval for a solvent-free manufacturing process for GelrinC, increasing yield by 400% and ...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced promising safety results from its Phase 1 trial of ENV-105 combined with osimertinib for resistant EGFR-mutated NSCLC, support...
BioAdaptives to Launch XcellaraHeart, Combining Stem Cell Mobilization with Cardiovascular Signaling Support
BioAdaptives announces the Aug. 1 launch of XcellaraHeart, a cardiovascular wellness supplement that pairs its clinically proven stem cell mobilizatio...
NeuroThera Labs Initiates Phase IIb Trial for Tourette Syndrome Treatment at Hannover Medical School
NeuroThera Labs has started its Phase IIb clinical trial of SCI-110, a cannabinoid-based treatment for Tourette Syndrome, at Hannover Medical School, ...
Survival Rates for Adults with Congenital Heart Disease Linked to Access to Specialized Cardiac Care, Study Finds
A new study published in the Journal of the American Heart Association reveals that adults with congenital heart disease living in states with lower a...
Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG and OneSource Specialty Pharma have announced a strategic manufacturing partnership to leverage OneSource's biologics facility in Bangalor...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma is progressing its novel neuroprotective therapy LUCID-MS, designed to reverse myelin degradation in multiple sclerosis, into Phase ...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma progresses its potentially first-in-class multiple sclerosis therapy LUCID-MS to Phase 2 clinical trials after favorable Phase 1 res...
Expert Links Respiratory Infections to Cardiovascular Disease, Highlights Role of Vaccines and Diagnostics
Professor Colin Russell emphasizes the underrecognized link between respiratory infections and cardiovascular disease, urging vaccination and timely d...
VERAXA Biotech Leverages AI Partnership to Accelerate BiTAC Cancer Therapy Development
VERAXA Biotech's collaboration with AI-focused Ardigen aims to optimize target discovery for its BiTAC platform, highlighting how artificial intellige...
Uterine Fibroids Disproportionately Affect Women of Color – Non-Surgical UFE Offers Effective Alternative
The article highlights the high prevalence of uterine fibroids in women of color and promotes uterine fibroid embolization (UFE) as a non-surgical, ef...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech collaborates with Ardigen to integrate AI into its BiTAC pipeline, aiming to improve dual-target selection and reduce toxicity in cance...
Understanding Aortic Dissection After Senator Lindsey Graham's Death
The sudden death of U.S. Senator Lindsey Graham from an aortic dissection highlights the urgency of recognizing this life-threatening condition, its r...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides announced National Ethics Committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against Bundibugyo ebolavirus, p...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage, Reaching 145 Million Covered Lives
Tonix Pharmaceuticals announced a managed Medicare agreement for TONMYA, expanding its coverage to approximately 145 million covered lives, representi...
Thyroid Hormone T3 Shows Promise in Preventing Pediatric Brain Tumor Recurrence
A research team found that triiodothyronine (T3), a widely prescribed thyroid hormone, when combined with standard chemotherapy, enhanced effectivenes...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech AG has partnered with Ardigen S.A. to integrate artificial intelligence into its BiTAC pipeline, aiming to enhance target selection and...
Onco-Innovations Completes Analytical Reference Standard Program for ONC010, Advancing Toward Clinical Readiness
The completion of the analytical reference standard program for ONC010 strengthens Onco-Innovations' CMC framework, supporting regulatory and clinical...